Princeton University plans to offer students a meningitis vaccine not usually approved for use in the United States in an attempt to prevent an outbreak at the school from spreading, officials said on Monday.
The vaccine, which has been approved in Europe and Australia, is expected to be available on campus at no cost in early December, university officials said. It is recommended for all undergraduates, graduate students living in dormitories and students with some specific health conditions.
Students and faculty were notified of the decision in an email on Monday.
Six students at the university who were hospitalized with the disease earlier this year have recovered; a seventh, who was found to have it earlier this month, is being treated. University officials have encouraged students to stop sharing drinks and to avoid kissing.
The students have come down with a strain of the disease known as serogroup B, which is not covered by the meningitis vaccine that is widely available in the United States. The Food and Drug Administration will allow for the vaccine, called Bexsero, to be used only in this case. Meningitis can cause infections that can maim or kill people within hours.
0 komentar:
Posting Komentar